← Evidence map

ReviewEJNMMI research2026

Glypican-3 targeted radiopharmaceuticals for hepatocellular carcinoma: a review of molecular platforms.

Yue Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 42192025